US Pharma & Biotech Cardiology - PPC Market Share Analysis February 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Cardiology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Google AI Overview visibility for Pharma & Biotech Cardiology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency	Percentage
Frequency	67.5022822713
	32.4977177287

67%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency	Percentage
Frequency	20
	80

20%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent	Distribution
Investigational	2%
Transactional	8%
Navigational	0%
Seasonal	0%
Local	0%
Problem Solving	23%

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month

Share of Clicks - Last month
Domain	Share of clicks
repatha.com	50.49
repathahcp.com	14.49
lipitor.com	9.79
veltassa.com	6.06
leqviohcp.com	2.79
leqvio.com	1.79
attrubyhcp.com	1.34
vyndamax.com	1.15
amvuttra.com	0.99
goodrx.com	0.94
others	10.17

repatha.com - 50.49%
repathahcp.com - 14.49%
lipitor.com - 9.79%
veltassa.com - 6.06%
leqviohcp.com - 2.79%
leqvio.com - 1.79%
attrubyhcp.com - 1.34%
vyndamax.com - 1.15%
amvuttra.com - 0.99%
goodrx.com - 0.94%
others - 10.17%

In the PPC landscape, repatha.com dominates with 50.49% click share, overshadowing others. Meanwhile, repathahcp.com and lipitor.com follow, while “others” collectively hold 10.17%.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month

Share of Spend - Last Month
Date	lipitor.com	repatha.com	repathahcp.com	veltassa.com	leqviohcp.com	tryngolzahcp.com	leqvio.com	vyndamax.com	attrubyhcp.com	amvuttra.com
2026/02/01	0.03%	49.64%	31.25%	1.2%	4.19%	1.06%	2.23%	0.58%	0.47%	1.53%
2026/02/02	0%	51.1%	13.58%	3.76%	5.03%	3.27%	2.29%	2.95%	3.07%	1.9%
2026/02/03	0.03%	47.12%	20.7%	8.07%	2.34%	1.59%	0.96%	1.18%	1.29%	2.08%
2026/02/04	0.2%	50.01%	19.5%	7.1%	3.9%	0.36%	0.76%	0.74%	3.53%	2.68%
2026/02/05	0.1%	58.83%	15.89%	8.72%	2.36%	0.08%	0.52%	1.86%	2.14%	1.6%
2026/02/06	7.84%	62.84%	14.51%	5.07%	1.26%	0.03%	0.5%	0.64%	1.35%	1.33%
2026/02/07	0.34%	62.94%	10.06%	7.82%	2.1%	0.94%	0.19%	2.23%	2.18%	1.96%
2026/02/08	5.53%	59.07%	18%	1.43%	3.76%	0.03%	3.75%	0.19%	1.4%	1.55%
2026/02/09	0.23%	63.07%	17.26%	6.97%	1.65%	1%	1.07%	0.16%	1.35%	2.75%
2026/02/10	16.83%	52.61%	14.85%	2.39%	2.2%	0.12%	1.15%	1.23%	1.57%	0.94%
2026/02/11	0.43%	63.19%	17.68%	5.1%	3.41%	0.62%	1.83%	0.65%	1.15%	0.59%
2026/02/12	0.1%	58.83%	15.89%	8.72%	2.36%	0.08%	0.52%	1.86%	2.14%	1.6%
2026/02/13	7.82%	62.73%	14.48%	5.06%	1.26%	0.03%	0.67%	0.64%	1.35%	1.33%
2026/02/14	0.34%	62.93%	10.06%	7.82%	2.1%	0.94%	0.19%	2.23%	2.18%	1.96%
2026/02/15	5.52%	59.04%	17.99%	1.43%	3.76%	0.03%	3.81%	0.19%	1.4%	1.55%
2026/02/16	0.23%	63.03%	17.25%	6.97%	1.65%	1%	1.07%	0.16%	1.35%	2.74%
2026/02/17	0.22%	64.6%	13.57%	1.53%	4.85%	0.34%	5.33%	2.1%	0.96%	0.81%
2026/02/18	0.13%	55.87%	14.17%	7.82%	3.06%	0.7%	2.21%	0.93%	4.11%	4.91%
2026/02/19	0.21%	59.71%	12.77%	7.75%	2.04%	1.18%	1.43%	0.24%	2.53%	3.29%
2026/02/20	0.62%	53.49%	17.82%	9.49%	2.74%	0.23%	2.06%	1.71%	2.32%	2.89%
2026/02/21	21.27%	31.88%	13.66%	14.5%	3.4%	2.5%	1.76%	0.66%	1.61%	2.55%
2026/02/22	11.88%	38.78%	11.75%	9.66%	1.18%	2.1%	1.66%	1.47%	1.4%	2.46%
2026/02/23	2.28%	19.8%	10.85%	18.76%	3.45%	2.37%	2%	0.95%	1.73%	3.26%
2026/02/24	17.15%	27.83%	9.33%	5.31%	5.78%	2.28%	3.6%	3.73%	0.23%	2.59%
2026/02/25	0.32%	45.46%	12.53%	11.97%	0.44%	5.28%	0.63%	0.86%	0.69%	4.25%
2026/02/26	0.45%	48.02%	9.41%	19.44%	1.53%	0.64%	0.8%	3.22%	1.18%	1.54%
2026/02/27	0.02%	57.21%	8.78%	10.47%	2.52%	0.68%	2.48%	0.68%	0.55%	0.29%
2026/02/28	37.55%	31.52%	8.07%	6.24%	1.2%	1.01%	0.9%	0.54%	0.31%	0.31%

lipitor.com
repatha.com
repathahcp.com
veltassa.com
leqviohcp.com
tryngolzahcp.com
leqvio.com
vyndamax.com
attrubyhcp.com
amvuttra.com

In February 2026, Repatha.com dominated PPC spend, peaking at 64.6%. Lipitor.com saw a significant spike on February 28, reaching 37.55%. Veltassa.com and Repathahcp.com showed consistent fluctuations, while Amvuttra.com ended with a modest 0.31%.

Market Exposure

Competitor Count for US Pharma & Biotech Cardiology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month

Competitor Count - Last month
Date	Competitor Count
2026/02/01	44
2026/02/02	48
2026/02/03	49
2026/02/04	50
2026/02/05	47
2026/02/06	48
2026/02/07	45
2026/02/08	53
2026/02/09	48
2026/02/10	47
2026/02/11	47
2026/02/12	47
2026/02/13	48
2026/02/14	45
2026/02/15	53
2026/02/16	48
2026/02/17	42
2026/02/18	44
2026/02/19	41
2026/02/20	36
2026/02/21	31
2026/02/22	37
2026/02/23	37
2026/02/24	45
2026/02/25	39
2026/02/26	40
2026/02/27	39
2026/02/28	38

February began with 44 advertisers, peaking at 53 mid-month. A decline followed, ending with 38.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Cardiology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month

Market Loss & Market Gains - Last month
Name	Market Trend
lipitor.com	4.34%
veltassa.com	1.4%
leqvio.com	1.27%
baptistjax.com	0.75%
goodrx.com	0.7%
northsidecvi.com	-0.17%
naomiw.com	-0.27%
attrubyhcp.com	-0.29%
repathahcp.com	-3.27%
repatha.com	-7.32%

Lipitor.com surged with a 4.34% click share increase, while Repatha.com faced a significant 7.32% decline. Veltassa.com and Leqvio.com also saw positive growth, contrasting with Repathahcp.com’s drop.

Campaign Efficiency

US Pharma & Biotech Cardiology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	lipitor.com	repatha.com	repathahcp.com	thorne.com	veltassa.com	tryngolzahcp.com	leqviohcp.com	leqvio.com	amvuttra.com	attrubyhcp.com
2026/02/01	0.02%	19.36%	45.36%	1.14%	0.79%	2.24%	7.47%	5.87%	3.05%	0.5%
2026/02/02	0%	16.06%	20.6%	0.72%	2.46%	6.22%	9.65%	3.11%	3.63%	8%
2026/02/03	0.03%	20.44%	30.86%	0.39%	5.4%	2.9%	6.07%	3.45%	3.73%	1.86%
2026/02/04	0.21%	16.48%	29.4%	2.61%	4.79%	1.33%	8.78%	0.84%	5.21%	6.65%
2026/02/05	0.19%	25.38%	28.68%	2.66%	6.78%	0.19%	6.04%	2.01%	3.45%	6.19%
2026/02/06	23.59%	26.58%	24.24%	1.7%	3.89%	0.08%	3%	2.35%	3.01%	2.18%
2026/02/07	0.41%	25.59%	20.45%	0.95%	7.83%	1.82%	6.05%	0.43%	6%	8.65%
2026/02/08	13.98%	25.3%	27.34%	1.34%	0.92%	0.05%	7.8%	8.24%	2.88%	2.7%
2026/02/09	0.57%	31.02%	31.42%	0.64%	5.74%	1.84%	4.32%	3.94%	6.17%	2.77%
2026/02/10	38.35%	16.27%	22.87%	0.74%	1.7%	0.28%	3.8%	1.39%	1.35%	2.49%
2026/02/11	0.94%	28.5%	31.76%	2.81%	4.3%	1.07%	8.47%	5.09%	1.46%	2.92%
2026/02/12	0.19%	25.38%	28.68%	2.66%	6.78%	0.19%	6.04%	2.01%	3.45%	6.19%
2026/02/13	23.59%	26.58%	24.24%	1.7%	3.89%	0.08%	3%	2.35%	3.01%	2.18%
2026/02/14	0.41%	25.59%	20.45%	0.95%	7.83%	1.82%	6.05%	0.43%	6%	8.65%
2026/02/15	13.98%	25.3%	27.34%	1.34%	0.92%	0.05%	7.8%	8.24%	2.88%	2.7%
2026/02/16	0.57%	31.02%	31.42%	0.64%	5.74%	1.84%	4.32%	3.94%	6.17%	2.77%
2026/02/17	0.33%	30.05%	27.96%	0.62%	1.41%	0.82%	10.74%	11.2%	1.84%	2.32%
2026/02/18	0.29%	21.77%	23.44%	4.47%	6.14%	1.51%	5.56%	3.47%	10.08%	9.83%
2026/02/19	0.4%	20.62%	24.13%	4.03%	6.66%	3.14%	4.47%	2.55%	7.87%	6.75%
2026/02/20	1.47%	23.22%	30.16%	3.11%	7.54%	0.52%	6.39%	3.13%	6.41%	4.94%
2026/02/21	39.44%	9.19%	12.99%	3.6%	7.1%	4.73%	6.22%	2.56%	3.65%	1.38%
2026/02/22	22.35%	16.62%	14.46%	2.12%	4.74%	3.16%	2.22%	4.05%	3.34%	2.19%
2026/02/23	2.64%	8.36%	11.56%	1.57%	10.81%	3.51%	5.81%	2.14%	5.2%	2.67%
2026/02/24	30.41%	12.01%	9.75%	2.16%	2.47%	3.02%	7.25%	3.71%	3.36%	0.19%
2026/02/25	0.57%	23.6%	17.02%	3.35%	6.91%	8.11%	0.8%	2.07%	6.8%	0.7%
2026/02/26	1.1%	20.69%	12.85%	5.7%	15.67%	1.2%	4.48%	0.78%	6.98%	1.65%
2026/02/27	0.03%	27.12%	15.9%	5.15%	7.08%	1.56%	6.49%	3.84%	0.29%	0.61%
2026/02/28	55.81%	9.28%	7.41%	3.02%	2.63%	2.47%	1.72%	1.19%	0.28%	0.2%

lipitor.com
repatha.com
repathahcp.com
thorne.com
veltassa.com
tryngolzahcp.com
leqviohcp.com
leqvio.com
amvuttra.com
attrubyhcp.com

In February 2026, Lipitor.com saw fluctuating impressions, peaking at 55.81% on the 28th. Repatha.com maintained a steady presence, while Repathahcp.com started strong but declined. Thorne.com and Veltassa.com showed moderate activity. Tryngolzahcp.com and Leqviohcp.com had varied trends. Amvuttra.com and Attrubyhcp.com experienced ups and downs, ending the month with lower shares.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology - Last month

1
AMVUTTRA® (vutrisiran) | FDA-Approved Treatment https://www.amvuttra.com
Resources and Support Are Available for Adults Prescribed AMVUTTRA. Learn More by Visiting the Website and Ask Your Doctor if AMVUTTRA Is Right for You.
2
Treating High LDL-C Patients? - Dosing And Administration
HCPs, Effective And Consistent LDL-C Reduction May Be Possible For Your Patients. Did Your Patient Experience A Recent Cardiovascular Event?
3
Repatha® (evolocumab) - What Is Repatha®? https://www.repatha.com/
See if Repatha Is The Right Treatment For You. Learn More On The Official Patient Site.
4
Repatha® (evolocumab) - Dosing & Administration https://www.repathahcp.com/
Learn More About Repatha by Visiting the Official Product Website for Physicians. Watch Videos & Discover Insights from Healthcare Professionals...
5
Heart Medications http://www.secondscount.org/
Learn The Types Of Heart Medicines. Preventing Heart Attack Or Stroke. Cardiovascular Health. Advancing Patient Care. Promoting Healthy Hearts. Founded in 1978.

In the competitive landscape of cardiology PPC ads, AMVUTTRA® stands out with its FDA-approved treatment focus, offering resources and support. Leqvio targets healthcare professionals with LDL-C reduction insights, while Repatha® emphasizes patient suitability and professional guidance. SecondsCount.org promotes heart health education, underscoring its long-standing commitment since 1978.

Frequently Asked Questions

Why is the US Pharma & Biotech Cardiology February 2026 Report useful and how should I use it?

Why is the US Pharma & Biotech Cardiology February 2026 Report useful?

Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.

Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.

How to use the US Pharma & Biotech Cardiology February 2026 Report
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
How often is the data updated?

Data within the US Pharma & Biotech Cardiology February 2026 Report is aggregated every month, highlighting the most significant changes from the previous period.
How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
How accurate is the US Pharma & Biotech Cardiology February 2026 Report?

The US Pharma & Biotech Cardiology February 2026 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Does this include mobile, desktop and Google Shopping data?

Yes. The US Pharma & Biotech Cardiology February 2026 Report aggregates data from across both device types and Google Shopping.
Who is this US Pharma & Biotech Cardiology February 2026 Report for?

The US Pharma & Biotech Cardiology February 2026 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Can I get a custom report for my brand?

Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
What is Ask Arlo?

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance.

Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Pharma & Biotech Cardiology - PPC Market Share Analysis February 2026

Cardiology – US

Google AI Overview visibility for Pharma & Biotech Cardiology US

AIO Frequency

Complex Query Frequency

Search Intent Distribution

Share of Clicks for top 10 US Pharma & Biotech Cardiology brands

Share of Spend for the top 10 US Pharma & Biotech Cardiology brands

Competitor Count for US Pharma & Biotech Cardiology

Market Loss & Market Gains for US Pharma & Biotech Cardiology

US Pharma & Biotech Cardiology Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Cardiology

Frequently Asked Questions

Why is the US Pharma & Biotech Cardiology February 2026 Report useful and how should I use it?

Why is the US Pharma & Biotech Cardiology February 2026 Report useful?

How often is the data updated?

How does Adthena collect this data?

How accurate is the US Pharma & Biotech Cardiology February 2026 Report?

Does this include mobile, desktop and Google Shopping data?

Who is this US Pharma & Biotech Cardiology February 2026 Report for?

Can I get a custom report for my brand?

What is Ask Arlo?

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Sage case study: 75% decrease in CPCs with Adthena

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Get the full picture

See this data specific to your brand performance

the7stars achieves Google Ads PPC campaign optimization with Adthena